XTI Aerospace (XTIA) announced that it intends to offer to sell shares of its common stock and warrants in a best-efforts public offering. All of ...

The aggregate gross proceeds to the Company from the offering and the warrant exercise are expected to be approximately $5.0 million, before deducting the placement agents’ fees and other offering ...

AUSTIN, TX / ACCESSWIRE / September 11, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial ...

WALTHAM, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (IVVD) (Invivyd) today announced the pricing of an underwritten public offering of 74,811,404 shares of its common stock at an offering ...

Crossroads Systems Inc. disclosed Tuesday the pricing of an offering of more than 3 million shares of its common stock and warrants to buy 1.5 million shares. © 2025 ...

Chijet said Tuesday that it planned to offer stock and warrants pursuant to a supplement to an August 2024 prospectus. The company, which operates in China, said Wednesday that the offering of 13.56 ...

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it ...

MALVERN, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the ...

Total gross proceeds of $100 million if all Series G warrants and Series H warrants are exercised for cash Financing was led by Balyasny Asset Management and included participation from Cormorant ...

BioVie (NASDAQ:BIVI) has priced a public offering of 6 million units at $2.00 per unit, raising approximately $12 million in gross proceeds. Each unit includes one share of common stock and one ...

CARSON CITY, Nev., Aug. 07, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI, BIVIW), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic ...